Palvella Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Palvella Therapeutics, Inc. (PVLA) reported Earnings Per Share, Basic and Diluted of -$0.07 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-17
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.07.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.26.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.09.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.07.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$0.68.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.56.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.50.
- Palvella Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$0.40.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 16 month |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | -$0.07 10-Q · filed 2021-05-17 | ||||||
| 2020-12-31 | -$0.68 10-K · filed 2021-03-31 | ||||||
| 2020-09-30 | -$0.26 10-Q · filed 2020-11-04 | -$0.42 10-Q · filed 2020-11-04 | |||||
| 2020-06-30 | -$0.09 10-Q · filed 2020-08-10 | -$0.16 10-Q · filed 2020-08-10 | |||||
| 2020-03-31 | -$0.07 10-Q · filed 2021-05-17 | ||||||
| 2019-12-31 | -$0.56 10-K · filed 2021-03-31 | ||||||
| 2019-09-30 | -$0.05 10-Q · filed 2020-11-04 | -$0.50 10-Q · filed 2020-11-04 | |||||
| 2019-06-30 | -$0.24 10-Q · filed 2020-08-10 | -$0.44 10-Q · filed 2020-08-10 | |||||
| 2019-03-31 | -$0.20 10-Q · filed 2020-05-11 | ||||||
| 2018-12-31 | -$0.50 10-K · filed 2020-03-13 | ||||||
| 2018-09-30 | -$0.11 10-Q · filed 2019-11-12 | -$0.29 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 | -$0.17 10-Q · filed 2019-08-09 | |||||
| 2018-03-31 | -$0.17 10-Q · filed 2019-05-10 | ||||||
| 2017-12-31 | -$0.40 10-K · filed 2019-03-18 | ||||||
| 2017-09-30 | -$0.16 10-Q · filed 2018-11-07 | -$0.58 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$0.23 10-Q · filed 2018-08-09 | -$0.42 10-Q · filed 2018-08-09 | |||||
| 2017-03-31 | -$0.19 10-Q · filed 2018-05-10 | ||||||
| 2016-12-31 | -$0.55 10-K · filed 2018-03-15 | ||||||
| 2016-09-30 | -$0.14 10-Q · filed 2017-11-13 | -$0.39 10-Q · filed 2017-11-13 | |||||
| 2016-06-30 | -$0.14 10-Q · filed 2017-08-11 | -$0.25 10-Q · filed 2017-08-11 | |||||
| 2016-03-31 | -$0.10 10-Q · filed 2017-05-15 | ||||||
| 2015-12-31 | -$0.41 10-K · filed 2017-03-30 | ||||||
| 2015-09-30 | -$0.10 10-Q · filed 2016-11-10 | -$0.34 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | -$0.12 10-Q · filed 2016-08-11 | -$0.25 10-Q · filed 2016-08-11 | |||||
| 2015-03-31 | -$0.13 10-Q · filed 2016-05-12 | ||||||
| 2014-12-31 | -$0.71 10-K · filed 2016-03-23 | ||||||
| 2014-09-30 | -$0.17 10-Q · filed 2015-11-13 | $0.00 10-Q · filed 2014-11-13 | -$0.48 10-Q · filed 2015-11-13 | $0.00 10-Q · filed 2014-12-12 | |||
| 2014-06-30 | -$0.24 10-Q · filed 2015-08-13 | -$0.31 10-Q · filed 2015-08-13 | $0.00 10-K · filed 2014-09-12 | ||||
| 2014-03-31 | -$0.07 10-Q · filed 2015-05-14 | $0.00 10-Q · filed 2014-06-02 | $0.00 10-Q · filed 2014-06-02 | ||||
| 2013-12-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 10-Q · filed 2014-05-14 | $0.01 10-K · filed 2015-03-30 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-12-12 | ||||||
| 2013-06-30 | $0.00 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |